Elan, Pfizer Didn't Hype Alzheimer's Drug, 2nd Circ. Hears
Elan Corp. PLC and Pfizer Inc. told the Second Circuit on Thursday that press releases it issued on clinical trials of an Alzheimer's drug were not misleading, contrary to investor class...To view the full article, register now.
Already a subscriber? Click here to view full article